Johnson & Johnson (JNJ) belonging to the Medical sector has declined -0.31% and closed its last trading session at $128.06.
The company reported its EPS on 01/24/2017. Currently, the stock has a 1 Year Price Target of $125.71.
The consensus recommendation, according to Zacks Investment research, is 2.44. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 2.37 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.26 and 2.16 respectively.
Johnson & Johnson on 01/24/2017 reported its EPS as $1.58 with the analysts projecting the EPS of the stock as $1.56. The company beat the analyst EPS Estimate with the difference of $0.02. This shows a surprise factor of 1.3%.
Many analysts have provided their estimated foresights on Johnson & Johnson Earnings, with 19 analysts believing the company would generate an Average Estimate of $1.76.
Whereas they predicted High and Low Earnings Estimate as $1.84 and $1.66 respectively. While in the same Quarter Previous year, the Actual EPS was $1.73.
Analysts are also projecting an Average Revenue Estimate for Johnson & Johnson as $18.02 Billion in the Current Quarter. This estimate is provided by 15 analysts.
The High Revenue estimate is predicted as 18.34 Billion, while the Low Revenue Estimate prediction stands at 17.77 Billion. The company’s last year sales total was 17.48 Billion.
For the Current Quarter, the growth estimate for Johnson & Johnson is 1.7%, while for the Next Quarter the stock growth estimate is 3.4%.
In the past 5 years, the stock showed growth of 6.39% per annum. While for the next 5 years, the growth estimate is 5.91%.
The Company got Downgrade by Wells Fargo on 26-Jan-17 from Outperform to Market Perform.
Insider Trades for Johnson & Johnson show that the latest trade was made on 2 Mar 2017 where Duato (Joaquin), the Officer completed a transaction type “Buy” in which 20842 shares were traded at a price of $61.75.
Over the period of 6 months, Insider Purchases show a total of 2 transaction in which 5000 shares were traded.
17 analysts projected Price Targets for Johnson & Johnson. The analysts believe that the company stock price could grow as high as $138. The Low Price target projection by analysts is $108 and the Mean Price Target is $125.71.
Johnson & Johnson (JNJ) has the market capitalization of $347.16 Billion. The company rocked its 52-Week High of $129 on Mar 15, 2017 and touched its 52-Week Low of $106.55 on Mar 21, 2016.
The stock has Return on Assets (ROA) of 11.9 percent. Return on Equity (ROE) stands at 22.9% and Return on Investment (ROI) of 17 percent.
The stock is currently showing YTD performance of 11.89 Percent. The company has Beta Value of 0.8 and ATR value of 1.35. The Weekly and Monthly Volatility stands at 1.02% and 1.11%.